SELP and myeloid sarcoma: Intriguingly, combined blockade of P-selectin and α4 integrins resulted in significantly better clinical outcome than anti-α4 integrin alone in EAE mice, suggesting that selectin blockade may have some therapeutic effect in MS as well (Kerfoot et al., 2006).